MafA transcription factor is phosphorylated by p38 MAP kinase

被引:38
|
作者
Sii-Felice, K
Pouponnot, C
Gillet, S
Lecoin, L
Girault, JA
Eychène, A
Felder-Schmittbuhl, MP
机构
[1] Ctr Univ Orsay, Inst Curie, UMR 146, CNRS, F-91405 Orsay, France
[2] Ctr Univ Orsay, Inst Biochim & Biophys Mol & Cellulaire, UMR 8619, CNRS, F-91405 Orsay, France
[3] INSERM, Inst Moulin, U536, F-75005 Paris, France
[4] Ctr Neurochim, UMR 7518, F-67000 Strasbourg, France
关键词
Maf; Kreisler; Nrl; lens; MAPK-1; API;
D O I
10.1016/j.febslet.2005.04.086
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Basic-leucine zipper transcription factors of the Maf family are key regulators of various developmental and differentiation processes. We previously reported that the phosphorylation status of MafA is a critical determinant of its biological functions. Using Western blot and mass spectrometry analysis, we now show that MafA is phosphorylated by p38 MAP kinase and identify three phosphoacceptor sites: threonine 113 and threonine 57, evolutionarily conserved residues located in the transcription activating domain, and serine 272. Mutation of these residues severely impaired MafA biological activity. Furthermore, we show that p38 also phosphorylates MafB and c-Maf. Together, these findings suggest that the p38 MAP kinase pathway is a novel regulator of large Maf transcription factors. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:3547 / 3554
页数:8
相关论文
共 50 条
  • [21] Activation and signaling of the p38 MAP kinase pathway
    Tyler ZARUBIN
    Cell Research, 2005, (01) : 11 - 18
  • [22] Benzothiazole based inhibitors of p38α MAP kinase
    Liu, Chunjian
    Lin, James
    Pitt, Sidney
    Zhang, Rosemary F.
    Sack, John S.
    Kiefer, Susan E.
    Kish, Kevin
    Doweyko, Arthur M.
    Zhang, Hongjian
    Marathe, Punit H.
    Trzaskos, James
    Mckinnon, Murray
    Dodd, John H.
    Barrish, Joel C.
    Schieven, Gary L.
    Leftheris, Katerina
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (06) : 1874 - 1879
  • [23] Synthesis of a naphthyridone p38 MAP kinase inhibitor
    Chung, John Y. L.
    Cvetovich, Raymond J.
    McLaughlin, Mark
    Amato, Joseph
    Tsay, Fuh-Rong
    Jensen, Mark
    Weissman, Steve
    Zewge, Daniel
    JOURNAL OF ORGANIC CHEMISTRY, 2006, 71 (22): : 8602 - 8609
  • [24] Imidazopyrimidines, potent inhibitors of p38 MAP kinase
    Rupert, KC
    Henry, JR
    Dodd, JH
    Wadsworth, SA
    Cavender, DE
    Olini, GC
    Fahmy, B
    Siekierka, JJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (03) : 347 - 350
  • [25] Mechanism of p38 MAP kinase activation in vivo
    Brancho, D
    Tanaka, N
    Jaeschke, A
    Ventura, JJ
    Kelkar, N
    Tanaka, Y
    Kyuuma, M
    Takeshita, T
    Flavell, RA
    Davis, RJ
    GENES & DEVELOPMENT, 2003, 17 (16) : 1969 - 1978
  • [26] P38 MAP kinase inhibitors for the treatment of arthritis
    Barlocco, D
    Langston, S
    DRUG DISCOVERY TODAY, 2001, 6 (15) : 808 - 809
  • [27] Activation and signaling of the p38 MAP kinase pathway
    Zarubin, T
    Han, JH
    CELL RESEARCH, 2005, 15 (01) : 11 - 18
  • [28] Role of p38 MAP kinase in myocardial stress
    Nagarkatti, DS
    Sha'afi, RI
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1998, 30 (08) : 1651 - 1664
  • [29] Immunolocalization of p38 MAP kinase in mouse brain
    Maruyama, M
    Sudo, T
    Kasuya, Y
    Shiga, T
    Hu, BR
    Osada, H
    BRAIN RESEARCH, 2000, 887 (02) : 350 - 358
  • [30] Practical Synthesis of a p38 MAP Kinase Inhibitor
    Achmatowicz, Michal
    Thiel, Oliver R.
    Wheeler, Philip
    Bernard, Charles
    Huang, Jinkun
    Larsen, Robert D.
    Faul, Margaret M.
    JOURNAL OF ORGANIC CHEMISTRY, 2009, 74 (02): : 795 - 809